JOURNAL CONTENT
CONTACT

Submission of the manuscript is online via e-mail
ecgarticle@gmail.com or
cholerez@mail.ru

Tel: +7 903 250 5288

Editorial Correspondence e-mail
gastrossr@gmail.com


Publishing, Subscriptions, Sales and Advertising, Correspondence e-mail
journal@cniig.ru

Tel: +7 917 561 9505

THE RULES OF SUBMITTING AN ARTICLE

READ

Scimago Journal & Country Rank

SCImago Journal & Country Rank

EXPERIENCE EXCHANGE

      1. The city center of diagnosis and treatment of inflammatory bowel diseases (St. Petersburg, Russian Federation)
      2. City clinical hospital № 31 (St. Petersburg, Russian Federation)

    Keywords:IBD,optimization of medical care,specialized centers,multidisciplinary collaboration

    Abstract:Optimal management (treatment and monitoring) of patients with Crohn’s disease may in the specialty unit where medical services will be provided by a multidisciplinary team, the process of functioning of which is based on modern recommendations. However, not all gastroenterology departments or offices have the possibility of forming such a unit. The article presents the results of a 2010 survey of experts of the Russian group for the study of IBD. Only in 6 cities (42.8 per cent) care to patients was conducted jointly by the gastroenterologists and Coloproctologists. The lack of specialized IBD endoscopists were noted in three cases (16.7 %), and the morphologist is 8 (44,4 %) institutions. Software specializing in IBD by radiologists occurred in 39 %, dieticians - 11,1 %, psychologists - 39 %. Mandatory participation of the legal entities included in the programme of work only 9 (56 %). Less than half (44 %) of the respondents indicated that they have a certain algorithm of interaction with specialized in issues of IBD paediatric gastroenterologists and the same number reported in the center of the patient support programs, including school patients. An algorithm for optimization of specialized care for patients with IBD is proposed, which is carried out by providing outpatient and inpatient care in the framework of multidisciplinary collaboration of specialized gastroenterologists and coloproctology specialists on IBD.

      1. Molodecky N. A., Soon I. S., Rabi D. M. [et al.] Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 2012, vol. 142, № 1, pp. 46-54.
      2. Schoepfer A. M., Dehlavi M. A., Fournier N. [et al.] Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol., 2013, vol. 108, № 11, pp. 1744-1753.
      3. Panés J., O’Connor M., Peyrin-Biroulet L. [et al.] Improving quality of care in inflammatory bowel disease: what changes can be made today? J Crohns Colitis, 2014, vol. 8, № 9, pp. 919-926.
      4. Mikocka-Walus A.A., Andrews J. M., Bernstein C. N. [et al.] Integrated models of care in managing inflammatory bowel disease: a discussion. Inflamm Bowel Dis., 2012, vol. 18, № 8, pp. 1582-1587.
      5. Ricci C., Lanzarotto F., Lanzini A. The multidisciplinary team for management of inflammatory bowel diseases. Dig Liver Dis., 2008, vol. 40, Suppl. 2, pp. S 285-S 288.
      6. Altschuler A., Collins B., Lewis J. D. [et al.] Gastroenterologists’ attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis., 2008, vol. 14, № 7, pp. 992-999.
      7. Tan M., Holloway R. H., Lange K. [et al.] General practitioners’ knowledge of and attitudes to inflammatory bowel disease. Intern Med J., 2012, vol. 42, № 7, pp. 801-807.
      8. Cheung W. Y., Dove J., Lervy B. [et al.] Shared care in gastroenterology: GPs’ views of open access to out-patient follow-up for patients with inflammatory bowel disease. Fam Pract., 2002, vol. 19, № 1, pp. 53-56.
      9. Kaplan G. G., Seow C. H., Ghosh S. [et al.] Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol., 2012, vol. 107, № 12, pp. 1879-1887.
      10. Frolkis A. D., Dykeman J., Negron M. E. [et al.] Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology, 2013, vol. 145, № 5, pp. 996-1006.
      11. Calvet X., Panes J., Alfaro N. [et al.] Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. J Crohns Colitis, 2014, vol. 8, № 3, pp. 240-251.
      12. Kaplan G. G., McCarthy E. P., Ayanian J. Z. [et al.] Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology, 2008, vol. 134, № 3, pp. 680-687.
      13. Karanicolas P. J., Dubois L., Colquhoun P. H. [et al.] The more the better?: the impact of surgeon and hospital volume on in-hospital mortality following colorectal resection. Ann Surg., 2009, vol. 249, № 6, pp. 954-959.
      14. Burns E. M., Bottle A., Aylin P. [et al.] Volume analysis of outcome following restorative proctocolectomy. Br J Surg., 2011, vol. 98, № 3, pp. 408-417.
      15. Nguyen G. C., Steinhart A. H. The impact of surgeon volume on postoperative outcomes after surgery for Crohn’s disease. Inflamm Bowel Dis., 2014, vol. 20, № 2, pp. 301-306.
      16. Callahan M. A., Christos P. J., Gold H. T. [et al.] Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg., 2003, vol. 238, № 4, pp. 629-636.
      17. Papay P., Ignjatovic A., Karmiris K. [et al.] Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis, 2013, vol. 7, № 8, pp. 653-669.
      18. Eliakim R., Magro F. Imaging techniques in IBD and their role in follow-up and surveillance. Nat Rev Gastroenterol Hepatol., 2014, vol. 11, № 12, pp. 722-736.
      19. Van Der Eijk I., Verheggen F. W., Russel M. G. [et al.] “Best practice” in inflammatory bowel disease: an international survey and audit. Eur J Intern Med., 2004, vol. 15, № 2, pp. 113-120.
      20. Magro F., Langner C., Driessen A. [et al.] European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis, 2013, vol. 7, № 10, pp. 827-851.
      21. Elkjaer M., Moser G., Reinisch W. [et al.] IBD patients need in health quality of care ECCO consensus. J Crohns Colitis, 2008, vol. 2, № 2. pp. 181-188.
      22. Jaff J. C., Arnold J., Bousvaros A. Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers. Inflamm Bowel Dis., 2006, vol.12, № 8, pp. 814-823.
      23. O’Connor M., Bager P., Duncan J. [et al.] N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn’s disease or ulcerative colitis. J Crohns Colitis, 2013, vol 7, № 9, pp. 744-764.
      24. Hernandez-Sampelayo P., Seoane M., Oltra L. [et al.] Contribution of nurses to the quality of care in management of inflammatory bowel disease: a synthesis of the evidence. J Crohns Colitis, 2010, vol 4, № 6, pp. 611-622.
      25. Guarini A., Marinis F., Kohn A. [et al.] Inflammatory bowel disease nurse specialists for patients on biological therapies: a nationwide Italian survey. Ann Gastroenterol., 2016, vol. 29, № 4, pp. 492-496.
      26. Kemp K., Fernandez E., Arnott I. Impact of inflammatory bowel disease nurse specialist on quality of the patient journey. J Crohns Colitis, 2013, vol. 7, suppl. 1, p. 203.
      27. Leach P., De Silva M., Mountifield R. [et al.] The effect of an inflammatory bowel disease nurse position on service delivery. J Crohns Colitis, 2014, vol. 8, № 5, pp. 370-374.
      28. Pearson C. Establishing an inflammatory bowel disease service. Nurs Times, 2006, vol. 102, № 23, pp. 28-29.
      29. Nightingale A. J., Middleton W., Middleton S. J. [et al.] Evaluation of the effectiveness of a specialist nurse in the management of inflammatory bowel disease [IBD]. Eur J Gastroenterol Hepatol., 2000, vol. 12, № 9, pp. 967-973.
      30. Davey Smith G., Watson R., Roger D. [et al.] Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease. J Adv Nurs., 2002, vol. 38, № 2, pp. 152-160.
      31. Rejler M., Spangeus A., Tholstrup J. [et al.] Improved population-based care: Implementing patient-and demand-directed care for inflammatory bowel disease and evaluating the redesign with a population-based registry. Qual Manag Health Care, 2007, vol. 16, № 1, pp. 38-50.
      32. Casellas F., Ginard D., Vera I. [et al.] Satisfaction of health care professionals managing patients with inflammatory bowel disease. J Crohns Colitis, 2013, vol. 7, № 7, pp. e249-e255.
      33. Siegel C. A. Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options. Gut 2012, vol. 61, № 3, pp. 459-465.
      34. Baars J. E., Markus T., Kuipers E. J. [et al.] Patients’ preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. Digestion, 2010, vol. 81, № 2, pp. 113-119.
      35. Hummel T. Z., Tak E., Maurice-Stam H. [et al.] Psychosocial developmental trajectory of adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr., 2013, vol. 57, № 2, pp. 219-224.
      36. Goodhand J., Hedin C. R., Croft N. M. [et al.] Adolescents with IBD: the importance of structured transition care. J Crohns Colitis, 2011, vol. 5, № 6, pp. 509-519.
      37. Selinger C. P., Eaden J., Selby W. [et al.] Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis, 2013, vol. 7, № 6, pp. e206-e213.
      38. Vavricka S. R., Brun L., Ballabeni P. [et al.] Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol., 2011, vol. 106, № 1, pp. 110-119.
      39. Stolwijk C., Pierik M., Landewe R. [et al.] Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease. Can J Gastroenterol., 2013, vol. 27, № 4, pp. 199-205.
      40. Danese S., Colombel J. F., Reinisch W. [et al.] Review article: infliximab for Crohn’s disease treatment shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther., 2011, vol. 33, № 8, pp. 857-869.
      41. Melmed G. Y., Siegel C. A., Spiegel B. M. [et al.] Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis., 2013, vol. 19, № 3, pp. 662-668.
      42. Wong S., Walker J. R., Carr R. [et al.] The information needs and preferences of persons with longstanding inflammatory bowel disease. Can J Gastroenterol., 2012, vol. 26, № 8, pp. 525-531. Zolnierek K. B., Dimatteo M. R. Physician communication and patient adherence to treatment: a meta-analysis. Med Care, 2009, vol. 47, № 8, pp. 826-834.
      43. Aguas Peris M., Del Hoyo J., Bebia P. [et al.] Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis. 2015, vol. 21, № 2, pp. 392-399.
     


    Full text is published :
    Shchukina O.B., Grigorian V.V. ORGANIZATION OF SPECIALIZED UNITS - CENTERS OF IBD AS A WAY OF OPTIMIZING MEDICAL CARE FOR PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE. Experimental and Clinical Gastroenterology Journal. 2017;146(10):116-123
    Read & Download full text